Home › Interstitial Lung Diseases › Illinois › Cicero
Interstitial Lung Diseases clinical trials in Cicero, IL
3 studies for Interstitial Lung Diseases are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Loyola University Health System, Maywood · 5 mi away
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Loyola University Medical Center, Maywood · 5 mi away
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
- Kansas City, KS13 studies
- Charleston, SC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Phoenix, AZ9 studies
- Salt Lake City, UT9 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Acute Myeloid Leukemia11 studies
- Breast Cancer11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Metastatic Cancer7 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Burkitt Lymphoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.